you are here:

SOLARA ACTIVE PHARMA SCIENCES Ltd.

BSE: 541540 | NSE: SOLARA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE624Z01016 | SECTOR: Pharmaceuticals

BSE Live

Jul 28, 16:00
1657.00 -68.45 (-3.97%)
Volume
AVERAGE VOLUME
5-Day
4,336
10-Day
4,775
30-Day
7,305
3,582
  • Prev. Close

    1725.45

  • Open Price

    1726.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jul 28, 16:01
1655.25 -74.55 (-4.31%)
Volume
AVERAGE VOLUME
5-Day
109,865
10-Day
76,182
30-Day
77,259
92,420
  • Prev. Close

    1729.80

  • Open Price

    1700.00

  • Bid Price (Qty.)

    1655.25 (2138)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON SOLARA ACTIVE P

  • Jul 28, 2021 16:44 Source: BSE

    SOLARA ACTIVE PHARMA SCIENCES - Intimation To Members About Annual General Meeting And Record Date For The Purpose Of Final Dividend

    We wish to inform you that 4th Annual General Meeting ('AGM') of the Company will be held over video conference/ other audio-visual means on Wednesday, August 25, 2021 at 10:30 a.m (IST) in compliance with the circulars issued by the Ministry of Corporate Affairs ('MCA'), Government of India and Securities and Exchange Board of India ('SEBI') and all other applicable laws. As informed by the Company on May 6, 2021, Board of Directors has recommended a final dividend of Rs. 3.00 per share. The Record Date for the purpose of Final Dividend for FY 2020-2021 will be Friday, August 20, 2021. Final Dividend once approved by the Members in the ensuing AGM will be paid within 30 days from the date of approval. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Register of Members and Share Transfer Books of the Company will remain closed from August 21, 2021 to August 25, 2021 (both days inclusive)

  • Jul 28, 2021 16:39 Source: BSE

    SOLARA ACTIVE PHARMA SCIENCES - Corporate Action - Record Date For Final Dividend

    We wish to inform you that 4th Annual General Meeting ('AGM') of the Company will be held over video conference/ other audio-visual means on Wednesday, August 25, 2021 at 10:30 a.m (IST) in compliance with the circulars issued by the Ministry of Corporate Affairs ('MCA'), Government of India and Securities and Exchange Board of India ('SEBI') and all other applicable laws. As informed by the Company on May 6, 2021, Board of Directors has recommended a final dividend of Rs. 3.00 per share. The Record Date for the purpose of Final Dividend for FY 2020-2021 will be Friday, August 20, 2021. Final Dividend once approved by the Members in the ensuing AGM will be paid within 30 days from the date of approval. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Register of Members and Share Transfer Books of the Company will remain closed from August 21, 2021 to August 25, 2021 (both days inclusive).

  • Jan 01, 1970 5:30 Source: BSE

    SOLARA ACTIVE PHARMA SCIENCES - Announcement under Regulation 30 (LODR)-Investor Presentation

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Wednesday, August 4, 2021 to discuss its Q1 financial results.

  • Jul 27, 2021 15:56 Source: BSE

    SOLARA ACTIVE PHARMA SCIENCES - Board Meeting Intimation for -Intimation Of Board Meeting Under Regulation 29 (1) Of SEBI Listing Regulations On August 4, 2021

    Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2021 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday, August 4, 2021 to inter alia consider and approve, the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2021, amongst other matters. In accordance with the Company''s Code of Conduct to regulate, monitor and report trading by insiders, adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company is closed for the designated persons from July 1, 2021 till 48 hours after the announcement of financial results i.e. upto August 6, 2021 (both days inclusive).

  • Jul 19, 2021 16:25 Source: BSE

    SOLARA ACTIVE PHARMA SCIENCES - Shareholding for the Period Ended June 30, 2021

    Solara Active Pharma Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here

  • Jul 13, 2021 15:47 Source: BSE

    SOLARA ACTIVE PHARMA SCIENCES - Statement Of Investor Complaints For The Quarter Ended June 2021

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0000
    Name of the Signatory :- S Muralikrishna
    Designation :- Company Secretary and Compliance Officer

  • Jul 13, 2021 15:43 Source: BSE

    SOLARA ACTIVE PHARMA SCIENCES - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are forwarding herewith a copy of Certificate received from M/s. CAMEO CORPORATE SERVICES LIMITED the Registrar and Share Transfer Agent of the Company, for the quarter ended June 30, 2021 for your records.

  • Jul 02, 2021 15:26 Source: NSE

    Solara Active Pharma Sciences Limited

    Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated July 02, 2021, titled "Restoration of CEP for Ranitidine Hydrochloride Drug Substance granted by EDQM.".

  • Jul 02, 2021 14:33 Source: BSE

    SOLARA ACTIVE PHARMA SCIENCES - Announcement Under Regulation 30 - Restoration Of CEP For Ranitidine Hydrochloride Drug Substance Granted By EDQM

    Restoration of CEP for Ranitidine Hydrochloride Drug Substance granted by EDQM

  • Jun 30, 2021 17:20 Source: BSE

    SOLARA ACTIVE PHARMA SCIENCES - Closure of Trading Window

    In accordance with the the Company''s Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the securities of the Company shall be closed for designated persons and their relatives from July 1, 2021 till 48 hours from the date of declaration of unaudited financial results of the Company for the quarter ended June 30, 2021.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : May 06, 2021
Remark : Audited Results & Dividend